Location History:
- Chigasaki, JP (1999 - 2001)
- Kanagawa, JP (2011 - 2012)
- Kamakura, JP (2010 - 2013)
- Gotemba, JP (2022 - 2024)
Company Filing History:
Years Active: 1999-2024
Title: Kazuo Hattori: Innovator in Antitumor and Hyaluronic Acid Derivatives
Introduction
Kazuo Hattori is a prominent inventor based in Gotemba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumor activity and innovative hyaluronic acid derivatives. With a total of 10 patents to his name, Hattori's work has the potential to impact cancer treatment and drug delivery systems.
Latest Patents
Hattori's latest patents include an arylamide derivative that exhibits antitumor activity. This compound is represented by a specific general formula and is designed to stabilize the RAF/MEK complex, making it a promising candidate for treating cell proliferative disorders, especially cancers. Another notable patent involves a hyaluronic acid derivative modified with polyethylene glycol. This invention introduces various cationic, hydrophobic, and hydrophilic sites, enhancing the drug delivery capabilities of hyaluronic acid derivatives.
Career Highlights
Throughout his career, Kazuo Hattori has worked with reputable companies such as Chugai Pharmaceutical Co., Ltd. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.
Collaborations
Hattori has collaborated with notable colleagues, including Yasunori Kohchi and Nobuo Shimma. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Kazuo Hattori's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for advancements in cancer treatment and drug delivery systems.